President Donald Trump signed an executive order the White House says is aimed at "lowering drug prices and stopping foreign free-riding on American pharmaceutical innovation."

President Donald Trump announced that his administration would tackle rising drug costs in the United States by establishing “most favored nation” pricing, which would base the U.S. prices of pharmaceuticals on the lowest prices paid by other foreign nations.

Rep. Ro Khanna announced plans to introduce legislation to codify the president's directive aimed at lowering prescription drug costs in the country.